Splanchnic nerve block with botulinum toxin for therapy of chronic heart failure - mechanism of action (SPONGE-HF)

Eur J Heart Fail. 2023 Apr;25(4):594-596. doi: 10.1002/ejhf.2829. Epub 2023 Mar 21.

Authors

Marat Fudim^{1

2}, Kishan Parikh^{1

2}, Arun Ganesh³, Jeroen Molinger^{1

3}, Neil Ray³, Aubrie Coburn¹, Brian J Coyne¹, Ashley G Swavely¹, Jennifer Andrews¹, James Matthew Gray¹, Vishal N Rao^{1

2}, G Michael Felker^{1

4}, Salvador Borges-Neto^{1

4}, Adrian F Hernandez^{1

2}, Manesh R Patel^{1

2}

Affiliations

¹ Department of Medicine and Division of Cardiology, Duke University Medical Center, Durham, NC, USA.
² Duke Clinical Research Institute, Durham, NC, USA.
³ Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
⁴ Department of Radiology and Division of Nuclear Cardiology, Duke University Medical Center, Durham, NC, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Botulinum Toxins*
Heart Failure* / drug therapy
Humans
Splanchnic Nerves

Substances

Botulinum Toxins

Grants and funding

K23 HL151744/HL/NHLBI NIH HHS/United States